Shree Ganesh Biotech India Ltd
Incorporated in 1982, Shree Ganesh Biotech Ltd is in the trading of seeds and bhushi
- Market Cap ₹ 41.9 Cr.
- Current Price ₹ 1.05
- High / Low ₹ 1.89 / 0.70
- Stock P/E 99.7
- Book Value ₹ 1.57
- Dividend Yield 0.00 %
- ROCE 4.42 %
- ROE 3.33 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Stock is trading at 0.67 times its book value
- Debtor days have improved from 312 to 113 days.
- Company's working capital requirements have reduced from 105 days to 12.8 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 2.86% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.00 | 1.57 | 2.26 | 1.68 | 2.12 | 8.54 | 7.86 | 5.87 | 2.47 | 17.21 | 72.64 | 62.45 | 24.47 | |
0.60 | 1.07 | 1.84 | 1.17 | 1.47 | 4.78 | 4.36 | 4.08 | 2.23 | 16.50 | 69.19 | 60.30 | 24.63 | |
Operating Profit | 0.40 | 0.50 | 0.42 | 0.51 | 0.65 | 3.76 | 3.50 | 1.79 | 0.24 | 0.71 | 3.45 | 2.15 | -0.16 |
OPM % | 40.00% | 31.85% | 18.58% | 30.36% | 30.66% | 44.03% | 44.53% | 30.49% | 9.72% | 4.13% | 4.75% | 3.44% | -0.65% |
0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | -0.28 | 0.05 | 0.56 | 0.58 | |
Interest | 0.00 | 0.01 | 0.04 | 0.07 | 0.07 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.08 | 0.08 | 0.21 | 0.10 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 0.32 | 0.41 | 0.17 | 0.34 | 0.55 | 3.73 | 3.50 | 1.79 | 0.24 | 0.43 | 3.50 | 2.71 | 0.42 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 1.82% | 0.00% | 0.00% | 0.00% | 0.00% | 25.58% | 27.71% | 25.09% | |
0.32 | 0.41 | 0.17 | 0.34 | 0.54 | 3.73 | 3.50 | 1.79 | 0.24 | 0.32 | 2.53 | 2.04 | 0.42 | |
EPS in Rs | 0.09 | 0.11 | 0.05 | 0.09 | 0.15 | 1.01 | 0.95 | 0.04 | 0.01 | 0.01 | 0.06 | 0.05 | 0.00 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 45% |
5 Years: | 51% |
3 Years: | 194% |
TTM: | -67% |
Compounded Profit Growth | |
---|---|
10 Years: | 17% |
5 Years: | -10% |
3 Years: | 104% |
TTM: | -89% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -29% |
3 Years: | -45% |
1 Year: | 14% |
Return on Equity | |
---|---|
10 Years: | 5% |
5 Years: | 3% |
3 Years: | 3% |
Last Year: | 3% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 | 1.83 | 19.93 | 19.93 | 19.93 | 19.93 | 39.86 | 39.86 |
Reserves | 1.49 | 1.89 | 2.06 | 2.41 | 2.94 | 6.68 | 10.18 | 37.31 | 37.54 | 37.86 | 40.39 | 22.49 | 22.72 |
0.00 | 0.18 | 0.33 | 0.61 | 0.50 | 0.06 | 0.19 | 0.19 | 0.19 | 0.19 | 0.00 | 0.00 | 0.00 | |
0.39 | 0.45 | 0.08 | 0.12 | 0.03 | 10.87 | 14.16 | 6.66 | 7.06 | 16.64 | 33.24 | 17.18 | 13.58 | |
Total Liabilities | 3.71 | 4.35 | 4.30 | 4.97 | 5.30 | 19.44 | 26.36 | 64.09 | 64.72 | 74.62 | 93.56 | 79.53 | 76.16 |
1.95 | 2.26 | 2.38 | 2.40 | 2.32 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 3.06 | 3.22 | 0.00 | 0.00 |
1.55 | 1.88 | 1.71 | 2.36 | 2.77 | 19.44 | 26.36 | 64.08 | 64.72 | 71.56 | 90.34 | 79.53 | 76.16 | |
Total Assets | 3.71 | 4.35 | 4.30 | 4.97 | 5.30 | 19.44 | 26.36 | 64.09 | 64.72 | 74.62 | 93.56 | 79.53 | 76.16 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.22 | 0.19 | -0.07 | -0.04 | -12.94 | 2.23 | -0.50 | -1.01 | 2.36 | 3.57 | 10.54 | |
0.00 | -0.39 | -0.33 | -0.11 | 0.00 | 2.53 | -2.36 | -32.07 | 0.99 | -2.36 | -3.37 | -10.09 | |
0.00 | 0.18 | 0.14 | 0.28 | -0.11 | 10.42 | 0.13 | 32.58 | 0.00 | 0.00 | -0.19 | 0.00 | |
Net Cash Flow | 0.00 | 0.01 | 0.00 | 0.10 | -0.16 | 0.02 | 0.00 | 0.01 | -0.02 | 0.01 | 0.01 | 0.44 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 127.75 | 34.87 | 92.06 | 260.71 | 456.25 | 384.23 | 627.84 | 1,191.38 | 3,072.21 | 601.05 | 220.54 | 112.98 |
Inventory Days | 465.69 | 975.33 | 298.37 | 483.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days Payable | 159.43 | 263.28 | 20.28 | 46.27 | ||||||||
Cash Conversion Cycle | 434.01 | 746.92 | 370.15 | 697.69 | 456.25 | 384.23 | 627.84 | 1,191.38 | 3,072.21 | 601.05 | 220.54 | 112.98 |
Working Capital Days | 401.50 | 278.98 | 251.95 | 443.21 | 466.58 | 383.81 | 475.99 | 779.12 | 2,036.32 | 249.20 | 53.71 | 12.80 |
ROCE % | 10.13% | 11.63% | 5.17% | 9.04% | 12.25% | 54.34% | 33.70% | 5.14% | 0.42% | 1.23% | 5.92% | 4.42% |
Documents
Announcements
- Closure of Trading Window 9m
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb
- Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 13 Feb
- Regulations 30, 33 And Other Applicable Provisions Of The SEBI (LODR) Regulations, 2015 13 Feb
- Board Meeting Outcome for Un-Audited Financial Result Quarter Ended On 31St December 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015. 13 Feb
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Overview:[1]
Company does business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc., micronutrients, bio products, etc.